Super Micro Q1 FY2027 earnings review

Net sales rose 297.5% to $19.9B, and non-GAAP EPS beat the LSEG consensus by 47.2%.

Super Micro Computer · Q3 2026 · Published Nov 4, 2026 · By DeepCell AI · Sources

Super Micro Q1 FY2027 earnings review


Quarter ended Sep 30, 2026 (calendar Q3 2026)

For information only, not investment advice. No rating or price target.

1 · Super Micro Computer (SMCI) Q1 FY2027 earnings review

Net sales rose 297.5% to $19.9B, and non-GAAP EPS beat the LSEG consensus by 47.2%


  1. 1.Non-GAAP EPS of $1.81 beat the $1.23 LSEG consensus; net sales beat by 21.7%
  2. 2.Net sales topped the $19.5B high end of the Oct 20 preliminary range
  3. 3.The FY2027 net sales outlook midpoint rose to $77.0B from $68.5B
  4. 4.Cash used in operations was $434M as receivables and inventories rose
  5. 5.Shares rose 9.0% to $34.22 by 5:03 PM ET on Nov 3 as results and outlook beat
2

2 · Executive summary

Q1 non-GAAP EPS beat the LSEG consensus by 47.2%, and net sales beat it by 21.7%


Q1 FY2027 results vs. LSEG consensus

MetricActualConsensusVarianceResult
Non-GAAP diluted EPS$1.81$1.23+$0.58 / +47.2%Beat
Net sales$19.95B$16.39B+$3.56B / +21.7%Beat

Q1 FY2027 results vs. FactSet consensus (cross-check)

MetricActualConsensusVarianceResult
Non-GAAP diluted EPS$1.81$1.23+47.2%Beat
Net sales$19.95B$17.53B+13.8%Beat

Share price reaction, Nov 3, 2026

MeasureNov 3 close5:03 PM ETChange
SMCI (Nasdaq)$31.39$34.22+9.0%
3

3 · Q1 results vs. consensus

Supermicro guided Q2 net sales to $20.5B at the midpoint and raised the FY2027 midpoint 12.4%


Q2 FY2027 outlook vs. Q1 FY2027 actual

MetricQ2 FY2027 outlookQ1 FY2027 actualChange
Net sales range$19.50B–$21.50B$19.95B+2.8%
Non-GAAP diluted EPS range$1.66–$1.90$1.81-1.7%
GAAP diluted EPS range$1.59–$1.83$1.75-2.3%
Non-GAAP tax rate21.1%21.4%-30 bps
Non-GAAP diluted shares769M764M+0.6%

FY2027 net sales outlook, Nov 3 vs. Aug 11

MetricNov 3, 2026Aug 11, 2026Change
Low end$72.00B$65.00B+10.8%
High end$82.00B$72.00B+13.9%
Midpoint$77.00B$68.50B+12.4%
4

4 · Q2 and FY2027 guidance

Net sales rose 297.5% to $19.9B, and income from operations rose 1,032.7%


  1. Faster than Q4Net sales rose 79.4% from Q4 FY2026.
  2. Higher EBITDA marginAdjusted EBITDA margin rose to 11.2% from 6.7%.
  3. Net income roseGAAP net income rose 847.3% YoY.

Key figures, Q1 FY2027 vs. Q1 FY2026

$M unless notedQ1 FY2026Q1 FY2027YoY
Net sales$5,018M$19,946M297.5%
Gross profit$467M$2,541M443.7%
Income from operations$182M$2,064M1,032.7%
Net income$168M$1,594M847.3%
Non-GAAP net income$238M$1,334M459.9%
Adjusted EBITDA$335M$2,227M565.2%
5

5 · Q1 key financials

Net sales of $19.9B topped the high end of the Oct 20 preliminary range by 2.3%


Q1 FY2027 results vs. company guidance

Prior guidance (Aug 11), preliminary range (Oct 20) and actual

MetricPrior guidanceOct 20 preliminaryActual
Net sales$14.50B–$15.50B$18.50B–$19.50B$19.95B
Gross margin10.4%–10.8%12.0%–12.5%12.7%
Non-GAAP diluted EPS$1.01–$1.10n.a.$1.81
GAAP diluted EPS$0.89–$0.98n.a.$1.75
Net sales beat the high end of prior guidance by 28.7%; the Oct 20 update cited demand for AI platforms.CEO Charles Liang said “DCBBS is driving significant value for our customers”
6

6 · Results vs. company guidance

Net sales rose 79.4% from Q4 FY2026 to $19.9B as deferred revenue more than doubled


Net sales by quarter

$M, Q1 FY2026, Q4 FY2026 and Q1 FY2027

Net sales · Q1 FY2026: $5,018MNet sales · Q4 FY2026: $11,120MNet sales · Q1 FY2027: $19,946MQ1 FY2026Q4 FY2026Q1 FY2027$0.0M$5,000.0M$10,000.0M$15,000.0M$20,000.0M$25,000.0M$5,018M$11,120M$19,946M
Total deferred revenue rose 116.9% since June to $5,666M
7

7 · Net sales trend

Gross margin fell to 12.7% from 17.5% in Q4 FY2026, yet rose from 9.3% a year earlier


Gross margin by quarter

% of net sales, Q1 FY2026, Q4 FY2026 and Q1 FY2027

Gross profit rose 30.8% from Q4 FY2026 to $2,541M; the Oct 20 update tied margin above guidance to customer and product mix
8

8 · Gross margin trend

GAAP diluted EPS rose 573.1% to $1.75, and non-GAAP diluted EPS rose 417.1%


GAAP and non-GAAP diluted EPS

$ per share, Q1 FY2026 vs. Q1 FY2027

Non-GAAP diluted EPSGAAP diluted EPS

Preferred stock dividends were $76M, against none in Q1 FY2026
9

9 · GAAP vs. non-GAAP EPS

Operating margin rose to 10.4% from 3.6% as operating expenses fell to 2.4% of net sales


10

10 · GAAP and non-GAAP margins

Cash used in operations was $434M as receivables and inventories absorbed $6,037M


Net income to operating cash flow

$M, Q1 FY2027

Deferred revenue added $3,054M, and free cash flow was an outflow of $476M
11

11 · Operating cash flow

Cost of sales rose 282.5%, while research and development expense rose 31.1%


Cost of sales fell to 87.3% of net sales from 90.7%

Cost growth by line

% change YoY, Q1 FY2027

12

12 · Cost growth by line

Net debt rose $550M to $1,749M as cash and cash equivalents fell $624M


Balance sheet items

$M, Jun 30, 2026 vs. Sep 30, 2026

$MJun 30, 2026Sep 30, 2026
Cash and cash equivalents$7,521M$6,897M
Net debt$1,199M$1,749M
Inventories$12,896M$15,054M
Accounts receivable, net$6,125M$9,685M
Total deferred revenue$2,612M$5,666M
Inventories rose 16.7% since June to $15,054M, and receivables rose 58.1%
13

13 · Balance sheet and net debt

Q2 estimates depend on margin mix and working capital, with gross margin at 12.7%


Indicator
What to watch
Implication
Q1 FY2027 reading
Gross margin mix
Customer and product mix in Q2
Profit could grow slower than net sales
Gross margin -473 bps vs. Q4 FY2026
Working capital
Receivables and inventory build
Cash conversion could stay negative
Cash used in operations $434M
Final results
10-Q and closing review
Preliminary figures may change
Net sales $19.9B, unaudited
14

14 · Key risks to guidance

Appendix: supporting analysis for net sales


ClaimEvidenceCalculation
Sequential gainNet sales rose $8,826M from Q4 FY2026 net sales of $11,120MQ1 FY2027 less Q4 FY2026 net sales
Above prior guidanceNet sales were 33.0% above the $15.0B prior guidance midpointNet sales divided by guidance midpoint, less one
Above preliminary rangeNet sales were 5.0% above the $19.0B preliminary midpointNet sales divided by preliminary midpoint, less one
Deferred revenue buildCurrent deferred revenue rose to $4,329M from $1,578MReported balance sheet line
15

15 · Appendix: Net sales detail

Appendix: supporting analysis for profit and costs


ClaimEvidenceCalculation
Operating expenses roseTotal operating expenses rose 67.1% to $477MReported operating expense lines
Interest expense roseInterest expense was $83M, against $25MReported interest expense line
Tax rate roseGAAP effective tax rate was 21.4%, against 19.3%As reported by Supermicro
GAAP-to-non-GAAP EPS itemsNon-GAAP EPS exceeded GAAP EPS by $0.06 in Q1 FY2027 and $0.09 in Q1 FY2026Non-GAAP diluted EPS less GAAP diluted EPS
16

16 · Appendix: Profit and costs

Appendix: cash flow and capital support


ClaimEvidenceCalculation
Capex stayed smallCapex and equity investments were $47MPurchases of property, plant and equipment plus equity investment
Payables offset part of the buildHigher accounts payable added $474M to operating cash flowReported cash flow line
Net debt repaymentSupermicro repaid a net $82M of lines of credit and term loansRepayments less proceeds
Preferred dividends paidPreferred stock dividends paid were $64M in cashReported cash flow line
17

17 · Appendix: Cash and capital

Appendix: watch items behind outlook and risks


ClaimEvidenceCalculation
Implied second halfImplied second-half FY2027 net sales of $36,554M at the midpointsFY2027 midpoint less Q1 actual and Q2 midpoint
Implied quarterly run rateImplied second-half quarterly average of $18,277M, 10.8% below the Q2 midpointImplied second half divided by two
EPS midpointQ2 non-GAAP EPS midpoint of $1.78, against $1.81 in Q1Average of the low and high ends
Gross margin gapGross margin was -473 bps from Q4 FY2026Change in gross margin, in basis points
18

18 · Appendix: Implied H2 run rate

Appendix: operating expense and non-GAAP detail


Operating expense detail, $M

$M unless notedQ1 FY2026Q1 FY2027
Research and development$173M$227M
Sales and marketing$48M$133M
General and administrative$64M$117M
Total operating expenses$285M$477M

Non-GAAP net income to common, basic, $M

$M unless notedQ1 FY2026Q1 FY2027
GAAP net income$168M$1,594M
Preferred stock dividends-($76M)
Participating securities-($252M)
GAAP net income to common$168M$1,267M
Stock-based compensation$89M$100M
Income tax effect($19M)($20M)
Participating securities adjustment-($13M)
Non-GAAP net income$238M$1,334M
19

19 · Appendix: Opex and non-GAAP

Appendix: sources


  • Company: Supermicro Q1 FY2027 press release, Exhibit 99.1 to Form 8-K, Nov 3, 2026 — https://www.sec.gov/Archives/edgar/data/1375365/000137536526000026/exhibit991_20260930.htm
  • Company: Q1 FY2027 preliminary update, Exhibit 99.1 to Form 8-K, Oct 20, 2026 — https://www.sec.gov/Archives/edgar/data/1375365/000137536526000025/smcifirstquarterfy2027busi.htm
  • Company: Q4 FY2026 press release with Q1 and FY2027 guidance, Exhibit 99.1 to Form 8-K, Aug 11, 2026 — https://www.sec.gov/Archives/edgar/data/1375365/000137536526000021/exhibit991_20260630.htm
  • Consensus: LSEG via Reuters (U.S. News), Nov 3, 4:07 PM ET; share reaction reason — https://money.usnews.com/investing/news/articles/2026-11-03/super-micro-forecasts-quarterly-revenue-above-estimates-on-strong-ai-server-demand
  • Consensus cross-check: FactSet via Invezz, Nov 3 — https://invezz.com/news/2026/11/03/super-micro-stock-faces-earnings-test-as-options-signal-12-5-move/; TipRanks preview — http://www.tipranks.com/news/super-micro-computer-q1-earnings-are-on-nov-3-options-traders-brace-for-a-14-2-move-in-smci-stock
  • Share price reaction reason: Investing.com, Nov 3 — https://www.investing.com/news/stock-market-news/super-micro-computer-surges-6-as-earnings-guidance-top-estimates-4996413
  • Share price: CNBC quote, Nov 3 close and after-hours last trade at 5:03 PM ET — https://www.cnbc.com/quotes/SMCI; cross-checks: Yahoo Finance — https://finance.yahoo.com/quote/SMCI/; Public.com — https://public.com/stocks/smci/after-hours
20

20 · Sources

Important disclosures and disclaimer


For information only. This presentation is provided for information only. It is not investment, legal, tax or accounting advice, and it is not an offer, or a solicitation of an offer, to buy or sell any security.

No recommendation. It carries no rating, price target or buy, sell or hold view, and it was prepared without regard to any reader's investment objectives, financial situation or needs.

Sources and accuracy. Company figures come from Supermicro's press releases filed with its Form 8-K reports on November 3, October 20 and August 11, 2026. The Q1 FY2027 figures are preliminary and unaudited, and no Form 10-Q was on file when this deck was made. Consensus estimates (LSEG via Reuters, FactSet via Invezz) and share prices (CNBC, Yahoo Finance, Public.com) are third-party data, credited on the sources page. We have not independently verified third-party data and make no warranty that any information here is accurate, complete or timely.

Forward-looking statements. Company outlook, consensus estimates and the watch items in this deck are forward-looking. They rest on assumptions that may prove wrong, and actual results may differ materially.

Past performance. Past results, including those for Q1 FY2027, are not a reliable indicator of future results.

Non-GAAP measures. Non-GAAP figures, adjusted EBITDA and free cash flow follow Supermicro's own definitions. They supplement, and do not replace, GAAP results, and they may not be comparable with other companies' measures. Supermicro's press release reconciles them to GAAP.

No liability. No liability is accepted for any direct or indirect loss arising from the use of this presentation or its contents.

No affiliation. This presentation is not affiliated with, reviewed or endorsed by Super Micro Computer, Inc. and does not represent Supermicro's views. Company and product names belong to their owners.

How it was made. The deck was built with DeepCell, with figures linked to a model in the file. Readers should check the figures against the original filings and consult a qualified professional adviser before making any investment decision.

Date of analysis. The analysis reflects information available as of November 3, 2026, 5:03 PM ET, at the start of Supermicro's earnings call. It will not be updated for later events, and views may change without notice.

21

21 · Disclosures

Share this review

Send the link: it opens with the picture below, and every number on the page still opens its formula and source. The picture is free to download and share.

More earnings reviews

All earnings reviews
  • AMD · Q3 2026

    AMD Q3 2026 earnings review

    Q3 non-GAAP EPS beat the LSEG consensus by 7.2%, and the Q4 revenue outlook topped it by 4.9%.

    Nov 4, 202621 slides

  • Upstart · Q3 2026

    Upstart Q3 2026 earnings review

    Q3 diluted EPS of $0.33 beat consensus, but Upstart cut its 2026 revenue and Adjusted EBITDA guidance.

    Nov 4, 202621 slides

  • Shopify · Q3 2026

    Shopify Q3 2026 earnings review

    Q3 non-GAAP EPS beat consensus by 2.1%, but subscription revenue missed by 1.7%.

    Nov 4, 202621 slides

  • Eaton · Q3 2026

    Eaton Q3 2026 earnings review

    Q3 adjusted EPS beat consensus by 4.0%, and the 2026 adjusted EPS guide midpoint rose $0.25.

    Nov 4, 202621 slides

  • Pfizer · Q3 2026

    Pfizer Q3 2026 earnings review

    Q3 Adjusted EPS beat consensus by 19.2%, and Pfizer raised its 2026 revenue and EPS guidance.

    Nov 4, 202621 slides